Stockscreener 앱 받기
5.25
1.08%
0.0561
전일 마감가:
$5.1939
열려 있는:
$5.19
하루 거래량:
1,064
Relative Volume:
0.05
시가총액:
$374.80M
수익:
-
순이익/손실:
$-2.97M
주가수익비율:
-5.3138
EPS:
-0.988
순현금흐름:
$-1.18M
1주 성능:
+2.94%
1개월 성능:
-24.79%
6개월 성능:
-41.60%
1년 성능:
+0.00%
1일 변동 폭
$5.11
$5.2915
1주일 범위
$4.73
$5.37
52주 변동 폭
$4.73
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
5.2915 | 367.89M | 0 | -2.97M | -1.18M | -0.988 |
VRTX
Vertex Pharmaceuticals Inc
|
426.19 | 108.54B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
710.46 | 75.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
782.44 | 50.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.92 | 40.45B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
315.74 | 32.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Yd Bio Ltd 주식(YDES)의 최신 뉴스
Autoliv posts upbeat Q1 results, joins United Airlines, Royal Caribbean Cruises and other big stocks moving higher on Friday - MSN
YD Bio Limited Reports Financial Results for Full Year 2025, Achieves 17% Revenue Growth and Strategic Advances in Healthcare Innovations - Quiver Quantitative
After a $13.9M equity raise, YD Bio enters 2026 with $6M cash - Stock Titan
Going concern warning tops YD Bio (NASDAQ: YDES) 20-F risk disclosures - Stock Titan
Immuneering Corp (IMRX) Stock Price, Quote, News & History - Benzinga
CMMB (Chemomab Therapeutics Ltd. American Depositary Share) posts narrower Q4 2025 loss than estimates, while shares dip modestly.Community Trade Ideas - Xã Thanh Hà
[Form 3/A] YD Bio Ltd Amended Initial Statement of Beneficial Ownership - Stock Titan
Shao Ta Lu Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday - Sahm
Man Edmund Hen Net Worth (2026) - GuruFocus
Bo Xiang Zhang Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Movi - Benzinga
GFL ENVIRONMENTAL INC. (GFL) - MSN
How does macroeconomics affect YD Bio (YDES) Stock | Price at $5.97, Down 4.57%Crowd Sentiment Stocks - Newser
YDES Technical Analysis & Stock Price Forecast - Intellectia AI
YDES SEC FilingsYD Bio Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
YD Bio (YDES) director receives $60,000 RSU grant and 2,081 shares - Stock Titan
Director at YD Bio (YDES) receives $60K RSU equity award - Stock Titan
YD Bio (NASDAQ: YDES) director Lu Shao-Ta files initial Form 3 - Stock Titan
Director Chang Kochi logs initial insider status at YD Bio Ltd (YDES) - Stock Titan
YD Bio launches telehealth platform for cancer detection By Investing.com - Investing.com South Africa
YD Bio launches telehealth platform for cancer detection - Investing.com
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States - The Manila Times
Yd Bio Limited and Eg Biomed Co., Ltd. Launch Nationwide Telehealth Platform - marketscreener.com
YD Bio (YDES) director files Form 3 with no share activity - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
[Form 3] YD Bio Ltd Initial Statement of Beneficial Ownership - Stock Titan
[Form 3] YD Bio Ltd Initial Statement o... - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
YD Life Sciences announced on the 23rd that its idiopathic pulmonary fibrosis treatment (IPF) "YDC10.. - 매일경제
YD Bio details roadmap for integrated oncology ecosystem - tipranks.com
YD Bio (YDES) CEO details direct and indirect share stakes - Stock Titan
Collective Metals Initiates Inaugural Drill Program at the Rocas Uranium Project in Southeast Athabasca Basin - The Manila Times
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem - Bitget
Inside YD Bio’s plan to link cancer detection with immunotherapy - Stock Titan
Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen - Defense World
NMFC PE Ratio & Valuation, Is NMFC Overvalued - Intellectia AI
Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen - Defense World
YD Bio (NASDAQ: YDES) registers 11.5M warrant shares; announces Taiwan-U.S. FDA alliance - Stock Titan
YD Bio Forms Taiwan-U.S. Dual-Core FDA Regulatory Platform in Alliance with YC Biotech - TipRanks
YD Bio (Nasdaq: YDES) builds Taiwan-U.S. FDA regulatory platform - Stock Titan
YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform - BioSpectrum Asia
YD Bio Says US Unit Selected as FDA Liaison for YC Biotech's Asia Clients - marketscreener.com
Yd Bio Limited announces strategic partnership with Yc Biotech Co - marketscreener.com
SunPower to Participate in the 38th Annual ROTH Conference - The Manila Times
Rumble App Now Includes Rumble Shorts on iPhones Following Apple Approval - The Manila Times
The Chefs’ Warehouse, Inc. to Participate in the UBS Global Consumer & Retail Conference - The Manila Times
Freshworks to Participate in Upcoming Investor Conferences - The Manila Times
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March - The Manila Times
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - The Manila Times
Prime Medicine to Participate in Upcoming Investor Conferences - The Manila Times
Yd Bio Ltd (YDES) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.78%
0.81%
자본화:
|
볼륨(24시간):